Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study
about
Prolactin signaling and Stat5: going their own separate ways?Gynaecomastia--pathophysiology, diagnosis and treatmentHigh expression of prolactin receptor is associated with cell survival in cervical cancer cells.Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-usersThe transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.Biological significance of prolactin in gynecologic cancers.Prolactin receptor-integrin cross-talk mediated by SIRPĪ± in breast cancer cells.Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.Gynecomastia: physiopathology, evaluation and treatment.Drug-induced gynecomastia.Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodiesDevelopment of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells.Complex prolactin crosstalk in breast cancer: new therapeutic implicationsGenetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in PolandCoexistence of lactating adenoma and invasive ductal adenocarcinoma of the breast in a pregnant womanMale breast carcinoma: increased awareness needed.Prolactin and the prolactin receptor: new targets of an old hormone.Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cellsConcurrent Lactating Adenoma and Infiltrating Ductal Carcinoma: A Case Report.Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments.Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.Hyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer.Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.Global profiling of prolactin-modulated transcripts in breast cancer in vivo.Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.Regulation of prolactin receptor levels and activity in breast cancerTransgenic models to study actions of prolactin in mammary neoplasia.Impaired turnover of prolactin receptor contributes to transformation of human breast cells.Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.Adverse effects of prolactin in rodents and humans: breast and prostate cancer.Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.Prolactin--to be reconsidered in canine mammary tumourigenesis?Amplification of the prolactin receptor gene in mammary lobular neoplasia.A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor.Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.
P2860
Q24800306-8F41E63B-AD8E-4C2D-9DE3-25B871FB03BBQ28245725-3392FE96-8788-4AEA-B02B-7693B44FA0EBQ33591458-0BCBE2B7-2952-44EB-A8B8-FFA23B77C90AQ33739284-B700CF34-B03C-489D-88A8-EC80D43E0C1AQ33783277-062CB151-B402-4DEA-BF10-77C244118C98Q34052860-B65FEC66-AB71-4640-BE7C-4A6F52C659E6Q34279935-A495F00D-C7A2-4D0E-AB06-D793AE466A8DQ34286753-3F03D6DE-875C-44E8-B03C-D14BF8AB73D2Q34287744-38F25029-EEE6-47A6-AF6D-9532B406E9F7Q34312712-33DE0FB3-BDDE-45F8-818B-A641434C7ECDQ34437651-7C4752C8-5FFA-40EC-B5E9-57B6AB807E98Q34442075-3C5C5254-7D0E-4E65-B035-8231F70F4662Q35165105-C80740FF-33F5-427C-A436-1899374046D0Q35303180-9FDAA334-61E8-47A3-8F11-76BAC677C7E4Q35559023-81685E34-3D2D-4673-9AA2-D481876EB697Q35588299-BE66F388-3C20-42D4-91AD-0EE8E36EC254Q35683518-27BB8A7A-9BAC-4E8C-85EE-0B853DA49CD2Q35932347-3AA79DD8-91C4-4873-8473-EC11B6F62932Q35990940-C1917476-7977-4C59-A9E2-EF7A7DD4B429Q36077297-B76994CB-5039-4A52-88A6-400AB594CB46Q36108837-B6B8EF23-EB5E-4452-9BA1-D7F96D6D817DQ36357467-2790C9C1-3FA2-425B-8F94-AED970A5FE93Q36560758-C49C71FB-10DD-48DE-A0AE-78A5E3D5C77CQ36884424-7632211E-AD72-43F8-9299-28FB346E222DQ36936457-02C7FFAC-A50D-4861-8D47-ABF6CC915269Q36952878-CC547007-59FD-44F0-AE41-A34D3B850A70Q36955129-956B07AF-862A-4DED-A440-1016E840D40FQ37060370-78E818AE-163F-4BA8-97E7-3FA623B7F84AQ37064926-D7BE66A1-BCE3-4539-A968-BD92623928D4Q37149031-A95D3796-F3CA-4FCE-84DB-962D851DAEB9Q37164504-E723FBA7-DD31-4ED6-B770-9C5589309931Q37246047-6417EE8A-A147-4463-AD49-2E4370382B0EQ37531336-097C9642-4AF6-4E77-826E-56C6E2CA098AQ37723938-61674DD6-5562-4023-8C4A-F57308BF7C4FQ38022089-A270A0F5-B0B7-47E5-A8C0-DFDF74A344A1Q38415541-8BE85636-8C54-4A3B-B569-51C2875FDC73Q39421066-B55B9908-DA88-4355-BC55-5FB0F74C4C41Q39526838-1710A8FA-EACD-4DD1-B930-97BC686657A7Q39624452-DB2ED39F-F26D-4C0D-BCC1-51932D245625Q39736388-E1FB709F-E450-4687-9CCF-BC2AE98980B2
P2860
Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study
description
2001 nĆ® lÅ«n-bĆ»n
@nan
2001 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō“Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2001 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¤Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2001幓ć®č«ę
@ja
2001幓č«ę
@yue
2001幓č«ę
@zh-hant
2001幓č«ę
@zh-hk
2001幓č«ę
@zh-mo
2001幓č«ę
@zh-tw
2001幓č®ŗę
@wuu
name
Expression of prolactin recept ...... e: an immunohistological study
@ast
Expression of prolactin recept ...... e: an immunohistological study
@en
Expression of prolactin recept ...... e: an immunohistological study
@nl
type
label
Expression of prolactin recept ...... e: an immunohistological study
@ast
Expression of prolactin recept ...... e: an immunohistological study
@en
Expression of prolactin recept ...... e: an immunohistological study
@nl
prefLabel
Expression of prolactin recept ...... e: an immunohistological study
@ast
Expression of prolactin recept ...... e: an immunohistological study
@en
Expression of prolactin recept ...... e: an immunohistological study
@nl
P2093
P2860
P356
P1476
Expression of prolactin recept ...... e: an immunohistological study
@en
P2093
P2860
P304
P356
10.1136/JCP.54.12.956
P407
P577
2001-12-01T00:00:00Z